158 related articles for article (PubMed ID: 15907324)
1. DNA-binding dependent and independent functions of WT1 protein during human hematopoiesis.
Svensson E; Eriksson H; Gekas C; Olofsson T; Richter J; Gullberg U
Exp Cell Res; 2005 Aug; 308(1):211-21. PubMed ID: 15907324
[TBL] [Abstract][Full Text] [Related]
2. [Inhibitory effect of WT1 gene isoform transfection on proliferation of leukemia cell line NB4].
Shen HL; Chen ZX; Wang W; Cen JN; Hu SY; Zhao Y
Ai Zheng; 2006 Feb; 25(2):163-9. PubMed ID: 16480579
[TBL] [Abstract][Full Text] [Related]
3. Leukemia associated mutant Wilms' tumor gene 1 protein promotes expansion of human hematopoietic progenitor cells.
Vidovic K; Ullmark T; Rosberg B; Lennartsson A; Olofsson T; Nilsson B; Gullberg U
Leuk Res; 2013 Oct; 37(10):1341-9. PubMed ID: 23871158
[TBL] [Abstract][Full Text] [Related]
4. Wilms' tumor gene product WT1 arrests macrophage differentiation of HL-60 cells through its zinc-finger domain.
Deuel TF; Guan LS; Wang ZY
Biochem Biophys Res Commun; 1999 Jan; 254(1):192-6. PubMed ID: 9920756
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the DNA-binding and transcriptional repression activity of the Wilms' tumor gene product, WT1, by cAMP-dependent protein kinase-mediated phosphorylation of Ser-365 and Ser-393 in the zinc finger domain.
Sakamoto Y; Yoshida M; Semba K; Hunter T
Oncogene; 1997 Oct; 15(17):2001-12. PubMed ID: 9366517
[TBL] [Abstract][Full Text] [Related]
6. Forced expression of the Wilms tumor 1 (WT1) gene inhibits proliferation of human hematopoietic CD34(+) progenitor cells.
Svedberg H; Richter J; Gullberg U
Leukemia; 2001 Dec; 15(12):1914-22. PubMed ID: 11753613
[TBL] [Abstract][Full Text] [Related]
7. New insights into DNA-binding behavior of Wilms tumor protein (WT1)--a dual study.
Nurmemmedov E; Yengo RK; Uysal H; Karlsson R; Thunnissen MM
Biophys Chem; 2009 Dec; 145(2-3):116-25. PubMed ID: 19853363
[TBL] [Abstract][Full Text] [Related]
8. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
Han Y; San-Marina S; Yang L; Khoury H; Minden MD
Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
[TBL] [Abstract][Full Text] [Related]
9. Wilms tumor and the WT1 gene.
Lee SB; Haber DA
Exp Cell Res; 2001 Mar; 264(1):74-99. PubMed ID: 11237525
[TBL] [Abstract][Full Text] [Related]
10. N-ras oncogene-induced gene expression in human hematopoietic progenitor cells: upregulation of p16INK4a and p21CIP1/WAF1 correlates with myeloid differentiation.
Shen S; Passioura T; Symonds G; Dolnikov A
Exp Hematol; 2007 Jun; 35(6):908-19. PubMed ID: 17533045
[TBL] [Abstract][Full Text] [Related]
11. The Wilms' tumor suppressor Wt1 activates transcription of the erythropoietin receptor in hematopoietic progenitor cells.
Kirschner KM; Hagen P; Hussels CS; Ballmaier M; Scholz H; Dame C
FASEB J; 2008 Aug; 22(8):2690-701. PubMed ID: 18424770
[TBL] [Abstract][Full Text] [Related]
12. Wilms' tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells.
Vidovic K; Svensson E; Nilsson B; Thuresson B; Olofsson T; Lennartsson A; Gullberg U
Leukemia; 2010 May; 24(5):992-1000. PubMed ID: 20237505
[TBL] [Abstract][Full Text] [Related]
13. [The influence of different WT1 gene isoforms expression pattern on the differentiation of leukemia cell line NB4].
Shen HL; Chen ZX; Wang W; Cen JN; Hu SY; Zhao Y
Zhonghua Xue Ye Xue Za Zhi; 2005 Sep; 26(9):543-7. PubMed ID: 16468332
[TBL] [Abstract][Full Text] [Related]
14. A novel target for the Wilms' tumour suppressor protein (WT1) is bound by a unique combination of zinc fingers.
Little MH; Holmes G; Pell L; Caricasole A; Duarte A; Law M; Ward A; Wainwright B
Oncogene; 1996 Oct; 13(7):1461-9. PubMed ID: 8875984
[TBL] [Abstract][Full Text] [Related]
15. Constitutive expression of the Wilms' tumor gene (WT1) in the leukemic cell line U937 blocks parts of the differentiation program.
Svedberg H; Chylicki K; Baldetorp B; Rauscher FJ; Gullberg U
Oncogene; 1998 Feb; 16(7):925-32. PubMed ID: 9484784
[TBL] [Abstract][Full Text] [Related]
16. Expression of the Wilms' tumor gene (WT1) in normal hemopoiesis.
Baird PN; Simmons PJ
Exp Hematol; 1997 Apr; 25(4):312-20. PubMed ID: 9131006
[TBL] [Abstract][Full Text] [Related]
17. NUP98-HOXA9 induces long-term proliferation and blocks differentiation of primary human CD34+ hematopoietic cells.
Takeda A; Goolsby C; Yaseen NR
Cancer Res; 2006 Jul; 66(13):6628-37. PubMed ID: 16818636
[TBL] [Abstract][Full Text] [Related]
18. Expression of the Wilms' tumor suppressor gene, WT1, reduces the tumorigenicity of the leukemic cell line M1 in C.B-17 scid/scid mice.
Smith SI; Down M; Boyd AW; Li CL
Cancer Res; 2000 Feb; 60(4):808-14. PubMed ID: 10706085
[TBL] [Abstract][Full Text] [Related]
19. The Wilms tumour suppressor protein WT1 (+KTS isoform) binds alpha-actinin 1 mRNA via its zinc-finger domain.
Morrison AA; Venables JP; Dellaire G; Ladomery MR
Biochem Cell Biol; 2006 Oct; 84(5):789-98. PubMed ID: 17167543
[TBL] [Abstract][Full Text] [Related]
20. A splice variant of the Wilms' tumour suppressor Wt1 is required for normal development of the olfactory system.
Wagner N; Wagner KD; Hammes A; Kirschner KM; Vidal VP; Schedl A; Scholz H
Development; 2005 Mar; 132(6):1327-36. PubMed ID: 15716344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
